Skip to content
“ALS is a devastating disease.” This is a common refrain when talking about Amyotrophic Lateral Sclerosis (ALS), a nervous system disease that weakens muscles […]
Unlocking hope: AMP ALS is transforming ALS biomarker research Read More »
The new SAF Coalition, which seeks to promote sustainable aviation fuel (SAF), just added 10 new members—including the Biotechnology Innovation Organization (BIO)— according to
BIO joins new SAF Coalition promoting sustainable aviation fuel Read More »
Artificial intelligence (AI) is on everyone’s mind these days. In healthcare and biotech, AI is addressing some of the industry’s biggest challenges, as well
NIH Innovation Zone 2024: Modality.AI tackles remote neurological assessment Read More »
From oncology to AI to burgeoning biotech hubs worldwide, the 2024 BIO International Convention brought together the global biotech community to discuss key trends
BIO 2024: 5 takeaways about the biotech business ecosystem Read More »
June 19 is a day of dual significance: World Sickle Cell Day and Juneteenth. It’s a day of celebration, acknowledging the remarkable progress in
World Sickle Cell Day 2024: A day to celebrate, a day to reflect Read More »
The U.S. “industrial bioeconomy” contributed $210.4 billion to the GDP and added 643,992 domestic jobs in 2023, a report released June 11 showed. In
U.S. industrial bioeconomy generates $210B and 643,992 jobs Read More »
In implementing the Inflation Reduction Act (IRA), the Centers for Medicare and Medicaid Services (CMS) has made efforts to unnecessarily broaden the law with
CMS overreach will impede innovation Read More »
The U.S. Food and Drug Administration (FDA) approved the CAPVAXIVE™ vaccine to protect adults from bacteria that can cause pneumonia and invasive pneumococcal disease
FDA approves Merck’s vaccine against pneumococcus bacteria Read More »
The COVID pandemic underscored the reality of medical inequity worldwide, a longstanding issue reflected in clinical trials, particularly regarding the absence of race and
BIO 2024: Can data improve clinical trial diversity? Read More »
About 7% of all U.S. adults have experienced long COVID, according to new studies seeking to identify the scope of the problem and define
7% of U.S. adults had long COVID, find new studies Read More »
